Molecular Therapy - Methods & Clinical Development
Volume 9, 15 June 2018, Pages 203-210
Original ArticleA Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model
Under a Creative Commons license
open access
Keywords
immunocompetent mouse model
ccRCC
RENCA
kidney cancer
CRISPR/Cas9
non-integrated lentivirus
immunotherapy
Cited by (0)
- 10
These authors contributed equally to this work.
© 2018 The Authors.